He S&P 500 The index offers a paltry dividend yield of 1.1%. By that standard, even the consumer products giant Procter & Gamble‘s (NYSE: PG) The 2.8% yield seems high. Here’s why dividend lovers may want to consider P&G and the even higher yields offered by real estate-focused companies. Real estate income (NYSE: O) and pharmaceutical giant Pfizer (NYSE: PFE)when January comes to an end.
Realty Income’s dividend yield is 5.3%. The monthly dividend has been increased annually for 30 years. The dividend is supported by the investment-grade real estate investment trust’s (REIT) balance sheet and a generally conservative management approach.
Where to invest $1,000 right now? Our team of analysts has just revealed what they believe are the 10 best stocks to buy right now, by joining Stock Advisor. See the actions »
If you’re a conservative dividend investor, Realty Income could be a key investment. There’s just one problem. It is so large, with a portfolio of more than 15,500 properties, that it is a slow-moving industry giant. To put a number on it, the dividend has grown at a compound annual rate of 4.2% over the last three decades. That keeps pace with inflation or slightly exceeds it, but slow and steady is the name of the game with Realty Income.
Procter & Gamble is one of the world’s largest consumer staples companies. It focuses heavily on the high end of the markets it serves. That’s a problem today because economic concerns are prompting consumers to tighten their belts. In particular, the second quarter of its fiscal 2026 was difficult for the company, with a 1% volume decline offset by a 1% increase in prices. That led to organic sales remaining flat, which isn’t a great result.
However, it is better than its consumer staples peers that are seeing organic sales declines. Still, P&G stock has fallen about 15% from its 52-week high. That could create a buying opportunity for long-term investors in what is a highly reliable dividend stock. In fact, P&G is a member of the elite group of companies known as the Dividend Kings. It has increased its dividend annually for more than six decades.
Those stocks aren’t cheap per se, but the price-to-earnings ratio has fallen below its five-year average, suggesting at least a fair price for this reliable dividend payer with a 2.8% yield.
Pharmaceutical giant Pfizer’s dividend yield is 6.7%, the highest of this trio. This is because investors are concerned about the company’s upcoming patent expiration and its lack of success in finding new blockbuster drugs. To make matters worse, the company had a high-profile failure in the GLP-1 weight loss drug space. Investors are very pessimistic about Pfizer today.